Boston Medical Center, Reproductive Endocrinology
Boston, Massachusetts, 02118, United States
NCT Number: NCT06481319
This investigators will conduct a pilot study investigating the implementation of an infertility Patient Navigator (PN) program to mitigate challenges for underserved individuals at Boston Medical Center (BMC) seeking infertility care. The primary objective is to assess whether the PN program can significantly reduce time to completion of infertility evaluation and to initiation of fertility treatment (if recommended) for infertile patients from an underserved patient population.
The study aims are to:
1. evaluate the impact of the PN program on timelines including obtaining commercial insurance coverage for infertility, expediting labwork/imaging, weight management, and partner urology appointments, and initiating fertility treatment; and 2. ascertain the medical literacy of participants with a validated tool to assess the impact of low medical literacy on PN facilitation.
Participants will be contacted by the PN and provided with a survey instrument that will test their medical literacy. Then the PN will assist with scheduling cycle-based testing including labwork and uterine cavity evaluation, the partner's urology appointment, the patient's appointments such weight management/nutrition referral, mammograms (if indicated by age), and insurance counseling if the participant's current insurance does not cover infertility diagnostic testing and treatment. These tasks are part of pursuing fertility care at BMC.
Duration of evaluation and time to treatment in age-matched control patients from the year prior that did not have PN services will be utilized as a comparison group.
Regression analyses will be conducted to explore the association between utilization of a PN and pregnancy rates, considering potential confounding factors.
Establishment of the pilot program will enable the investigators to apply for a larger institutional patient care grant going forward. Strategies developed through this research can may enhance fertility care access for underserved communities across various healthcare settings. By tailoring interventions to populations not usually able to access specialized healthcare services, this study pioneers a paradigm shift towards inclusivity and equity in reproductive medicine.
This study is active but is not currently recruiting participants.
18 year–43 year
Female
Interventional
Not applicable
Boston, Massachusetts, 02118, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Intervention cases
Exclusion criteria
Assistance with infertility evaluation including scheduling appointments
Time frame: 12 months
This outcome will be assessed by data abstracted from the electronic medical record (EMR).
Time frame: 12 months
This outcome will be assessed by data abstracted from the EMR.
Time frame: 12 months
This outcome will be assessed by data abstracted from the EMR.
Time frame: 12 months
This outcome will be assessed by data abstracted from the electronic medical record.
Time frame: 12 months
This outcome will be assessed by data abstracted from the EMR by dividing the number of pregnancies by the number of participants.
Time frame: 12 months
This outcome will be assessed by data abstracted from the EMR.
Time frame: 12 months
This outcome will be assessed from data documented by the PN study records for each participant in the Intervention group
Time frame: 12 months
This outcome will be assessed from data documented by the PN study records for each participant in the Intervention group
Time frame: 12 months
This outcome will be assessed from data documented by the PN study records for each participant in the Intervention group
Boston Medical Center
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04549116
Genital Diseases, Infertility
Tempe, Arizona, United States
View Trial DetailsNCT07062237
Genital Diseases, Infertility
Farmington, Connecticut, United States
View Trial DetailsNCT04381299
Adnexal Diseases, Anti-Mullerian Hormone Deficiency
Abu Dhabi, Abu Dhabi Emirate, United Arab Emirates
View Trial DetailsNCT06375811
Endometriosis, Female Urogenital Diseases
Aurora, Colorado, United States
View Trial Details